P1456: EARLY SAFETY AND CLINICAL COURSE OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MEASURABLE RESIDUAL DISEASE RECEIVING GTA002, AN OFF-THE-SHELF, EX VIVO-CULTURED ALLOGENEIC NK CELL PREPARATION

Detalles Bibliográficos
Autores principales: Heuser, M., Fiedler, W., Block, A., de Leeuw, D. C., van de Loosdrecht, A., Astrid Tschan-Plessl, A., Passweg, J., Kloos, A., Schwarzer, A., Venturini, L., Duru, A. D., Pinkernell, K., Ganser, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429039/
http://dx.doi.org/10.1097/01.HS9.0000848680.66640.98

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429039/
http://dx.doi.org/10.1097/01.HS9.0000848680.66640.98

Ejemplares similares